tirzepatide y semaglutide Maintenance therapy on or Hair loss with GLP-1 drugs

According to research from 2025, people who stop taking GLP-1 medications without continuing lifestyle changes regain about 0.4 kg per month

Choosing the right medication for weight management is a significant step toward achieving your health goals

Healthline Mller, T

recommended for Type 2 on insulin therapy

What the Research and Trials Show The head-to-head evidence is unusually clear because these two compounds were tested directly against each other in more than one program

[42] Semaglutide remains contraindicated in individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2